• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
✕
  • Home
  • News
  • Business news
  • PolyPeptide attends TIDES Europe – Amsterdam, November 7th and 8th

PolyPeptide attends TIDES Europe – Amsterdam, November 7th and 8th

18 December 2018
Business news
Didier monnaie

We will be at stand #13. Simply stop by or schedule an appointment here: [email protected] 

PolyPeptide attends TIDES Europe in Amsterdam, Postillion Convention Center, November 7th and 8th. Contact us: [email protected] to set a meeting or come by our booth #13.

Want to learn more about “Successful Characterization of Peptide APIs & Setting the Specifications Optimally”? Join the presentation Thursday, November 8th, 12:40 – 13:10 with Didier Monnaie, Head of Analytical Department, PolyPeptide Group. Read more here

Back to news

Related posts

24 April 2025

Alzinova Advances ALZ-101 Development with Drug Substance Release, Paving the Way for Phase 2 Clinical Trial


Read more
27 August 2024

Vinnova grant awarded to joint project between PolyPeptide and Red Glead Discovery for developing a more sustainable manufacturing method for a GLP-1 agonist.


Read more
8 May 2023

PolyPeptide launches new “Innovation Lab”


Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2025 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers